LumaCyte

About:

LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis.

Website: http://www.lumacyte.com

Twitter/X: LumaCyte

Top Investors: Malvern Panalytical

Description:

LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis and sorting. Its patented technology empowers researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Its technology is intended to significantly broaden the horizons of medical research and shorten the time to powerful medical breakthroughs.

Total Funding Amount:

$6.81M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Keswick, Virginia, United States

Founded Date:

2012-01-01

Founders:

Renee Hart, Sean Hart

Number of Employees:

11-50

Last Funding Date:

2023-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai